Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now shows recruitment is closed and includes new help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revision update to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check19 days agoChange DetectedRevision from v3.5.4 to v3.5.5 is shown, signaling an updated study document version (e.g., protocol/SA plan) in the study record. This update indicates newer documentation is available for review.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating a minor page/template update to the entry that does not modify the study data.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s footer revision label is updated from **v3.5.2** to **v3.5.3**, indicating a site software/version refresh rather than a change to the clinical trial record.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.